Literature DB >> 2580249

Comparison of the effects of benzodiazepines and other anticonvulsant drugs on synthesis and utilization of 5-HT in mouse brain.

J A Pratt, P Jenner, C D Marsden.   

Abstract

Acute administration of clonazepam (0.5-8.0 mg/kg, i.p.), diazepam (2-32 mg/kg, i.p.), chlordiazepoxide (1-40 mg/kg, i.p.) or diphenylhydantoin (5-320 mg/kg, i.p.), caused a dose-related elevation of the concentrations of, 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and tryptophan in whole mouse brain. Carbamazepine (5-100 mg/kg, i.p.), and phenobarbitone (10-80 mg/kg, i.p.) raised the concentrations of 5-HT and 5-HIAA in the brain, whereas flurazepam (5-80 mg/kg, i.p.) only elevated the level of 5-HIAA. After administration of L[G-3H]tryptophan (25 microCi, s.c.), clonazepam (4 mg/kg), diazepam (32 mg/kg, i.p.), chlordiazepoxide (40 mg/kg) or diphenylhydantoin (40 mg/kg), but not carbamazepine (50 mg/kg), flurazepam (40 mg/kg) or phenobarbitone (80 mg/kg), increased the content of labelled tryptophan in brain. However, administration of drugs did not alter the incorporation of the label into [3H]5-HT, suggesting that the synthesis of 5-HT was unaffected. When incorporation of [3H]tryptophan into [3H]5-HT was complete and the pool of labelled 5-HT was decreasing, clonazepam, diazepam, chlordiazepoxide and diphenylhydantoin elevated the content of [3H]5-HT in brain. Flurazepam, phenobarbitone and carbamazepine were without apparent effect. Calculation of the rate of utilization of 5-HT (Km) showed that all drugs, apart from flurazepam, reduced the utilization of 5-HT. Using the rate of disappearance of 5-HT after inhibition of tryptophan hydroxylase by p-chlorophenylalanine (PCPA), all drugs, except flurazepam, diphenylhydantoin and phenobarbitone, decreased the utilization of 5-HT. The major action of the anticonvulsant drugs on the function of 5-HT in brain appears to be a decrease in the utilization of 5-HT without altering synthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580249     DOI: 10.1016/0028-3908(85)90096-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca(2+)- and K(+)-evoked serotonin release.

Authors:  Y Kawata; M Okada; T Murakami; A Kamata; G Zhu; S Kaneko
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  Effects of carbamazepine on 5-hydroxytryptamine function in rodents.

Authors:  M Elphick; S M Anderson; K F Hallis; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis.

Authors:  T Murakami; M Okada; Y Kawata; G Zhu; A Kamata; S Kaneko
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

4.  5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide.

Authors:  Caroline Fradette; Nobuharu Yamaguchi; Patrick Du Souich
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

5.  Competition for sucrose-pellets in triads of male Wistar rats: effects of acute and subchronic chlordiazepoxide.

Authors:  C Gentsch; M Lichtsteiner; H Feer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.